• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Chemical Profile of (S)-(1-Methylpiperidin-2-yl)methanol (CAS No. 136030-04-1)

(S)-(1-Methylpiperidin-2-yl)methanol, identified by its CAS number 136030-04-1, is a significant compound in the realm of pharmaceutical chemistry and biomedicine. This chiral alcohol, belonging to the piperidine family, has garnered considerable attention due to its versatile applications in drug development and molecular research.

The molecular structure of (S)-(1-Methylpiperidin-2-yl)methanol features a piperidine ring substituted with a methyl group at the 1-position and a hydroxymethyl group at the 2-position. The presence of the (S) configuration at the chiral center imparts unique stereochemical properties, making it a valuable intermediate in the synthesis of enantiomerically pure pharmaceuticals. This specificity is crucial in medicinal chemistry, where the biological activity of a drug can be profoundly influenced by its stereochemistry.

In recent years, advancements in synthetic methodologies have enabled more efficient and scalable production of (S)-(1-Methylpiperidin-2-yl)methanol. Modern techniques such as asymmetric hydrogenation and enzymatic resolution have been employed to achieve high enantiomeric purity, which is essential for pharmaceutical applications. These methods not only enhance yield but also minimize environmental impact, aligning with the growing emphasis on sustainable chemistry.

The utility of (S)-(1-Methylpiperidin-2-yl)methanol extends beyond its role as a building block in drug synthesis. It has been explored as a key intermediate in the development of novel therapeutic agents targeting various diseases. For instance, researchers have investigated its potential in creating ligands for G-protein coupled receptors (GPCRs), which are involved in numerous physiological processes and are common targets for therapeutic intervention. The chiral environment provided by the piperidine moiety allows for precise tuning of receptor binding affinity and selectivity.

Recent studies have also highlighted the importance of (S)-(1-Methylpiperidin-2-yl)methanol in the design of kinase inhibitors. Kinases are enzymes that play a pivotal role in cell signaling pathways, and their dysregulation is associated with several diseases, including cancer. By incorporating this compound into kinase inhibitor scaffolds, scientists have developed molecules with enhanced potency and reduced off-target effects. The hydroxymethyl group at the 2-position offers opportunities for further functionalization, enabling the creation of diverse pharmacophores.

The field of medicinal chemistry continues to evolve, with an increasing focus on personalized medicine and targeted therapies. (S)-(1-Methylpiperidin-2-yl)methanol serves as a testament to this progress, demonstrating how structural modifications can lead to more effective and tailored treatments. Its incorporation into drug candidates has contributed to significant breakthroughs in treating conditions such as neurological disorders and inflammatory diseases.

In addition to its pharmaceutical applications, (S)-(1-Methylpiperidin-2-yl)methanol has found utility in chemical biology research. Its chiral nature makes it an excellent probe for studying enzyme mechanisms and interactions. By using this compound as a substrate or inhibitor, researchers can gain insights into the structural and functional aspects of enzymes involved in critical metabolic pathways. This information is invaluable for developing new therapeutic strategies and understanding disease pathogenesis.

The synthesis and application of (S)-(1-Methylpiperidin-2-yl)methanol also underscore the importance of green chemistry principles. Efforts to optimize synthetic routes have focused on reducing waste generation, minimizing energy consumption, and utilizing renewable resources. These approaches not only improve economic feasibility but also contribute to environmental sustainability. As the demand for eco-friendly chemical processes grows, compounds like (S)-(1-Methylpiperidin-2-yl)methanol will play an increasingly vital role in sustainable pharmaceutical development.

In conclusion, (S)-(1-Methylpiperidin-2-yl)methanol (CAS No. 136030-04-1) is a multifaceted compound with significant implications in pharmaceutical chemistry and biomedicine. Its unique structural features and stereochemical properties make it an invaluable intermediate in drug development, while its versatility allows for diverse applications across multiple therapeutic areas. As research continues to advance, this compound will undoubtedly remain at the forefront of innovation in chemical biology and medicinal chemistry.

• 20845-34-5(1-Methyl-2-piperidinemethanol)
• 693288-49-2(1-Pentanol,2-(diethylamino)-(9CI))
• 68474-13-5([(2R)-1-methyl-2-piperidyl]methanol)
• 724415-75-2(2-Piperidinemethanol,1,6-dimethyl-(9CI))
• 918817-86-4(2-(Dibutylamino)hexadecan-1-ol)
• 135938-65-7(2-Piperidinemethanol,1-(1-methylethyl)-(9CI))
• 7013-15-2(Piperidinium,2-(hydroxymethyl)-1,1-dimethyl-)
• 1008-22-6(octahydro-2H-Quinolizine-4-methanol)
• 797789-72-1(1-Piperidineethanol,bta-hexyl-4-methyl-(9CI))
• 33742-65-3(2-(2-Methylpiperidin-1-yl)propan-1-ol)